Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program
第一作者机构:[1]Leiden Univ, Dept Thrombosis & Haemostasis, Med Ctr, Leiden, Netherlands;
推荐引用方式(GB/T 7714):
Huisman M. V.,Lip G. Y. H.,Diener H. C.,et al.Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program[J].EUROPEAN HEART JOURNAL.2014,35:777-777.
APA:
Huisman, M. V.,Lip, G. Y. H.,Diener, H. C.,Dubner, S. J.,Ma, C. S....&Halperin, J. L..(2014).Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program.EUROPEAN HEART JOURNAL,35,
MLA:
Huisman, M. V.,et al."Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program".EUROPEAN HEART JOURNAL 35.(2014):777-777